Changchuan(Charles) Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profileg
Changchuan(Charles) Jiang MD, MPH

@CharlesJiangMD

Hem/Onc Fellow class2023@RoswellPark
Interested in patient-centered GU onc, survivor/service/outcome research

SoochowUniv' MD, MPH @Yale , IM @msm_msw

ID:1157347705322188800

calendar_today02-08-2019 17:49:30

200 Tweets

399 Followers

487 Following

Fumiko Ladd Chino, MD(@fumikochino) 's Twitter Profile Photo

Dr Ryan Nipp, MD, MPH with an excellent summary on THREE randomized studies focused on improving the LIVED EXPERIENCE of cancer treatment and survivorship.

✅ We ARE moving the needle in advancing patient-centered care.

Dr @RyanNipp with an excellent summary #ASCO24 on THREE randomized studies focused on improving the LIVED EXPERIENCE of cancer treatment and survivorship. ✅ We ARE moving the needle in advancing patient-centered care.
account_circle
Changchuan(Charles) Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profile Photo

Important trial! oxybutinin 5mg bid provided strong benefits in reducing hot flashes for prostate cancer patients on ADT+/-abi. No safety concern.

Important #alliance trial! oxybutinin 5mg bid provided strong benefits in reducing hot flashes for prostate cancer patients on ADT+/-abi. No safety concern.
account_circle
Fumiko Ladd Chino, MD(@fumikochino) 's Twitter Profile Photo

Highlight of :

Being on stage w Dr Justin M. Barnes & giving back to back oral talks on HSR topics that have real solutions. We want our work to CHANGE healthcare in the US. Insurance should not be a barrier to cancer care & survivorship.

🇺🇸We can fix this.

Highlight of #ASCO24: Being on stage w Dr @Barnes_J_M & giving back to back oral talks on HSR topics that have real #healthypolicy solutions. We want our work to CHANGE healthcare in the US. Insurance should not be a barrier to cancer care & survivorship. 🇺🇸We can fix this.
account_circle
Dr. Iván R. González(@Dr_Ivanoncologo) 's Twitter Profile Photo

- Charles Jiang MD, MPH discussed 3 abstracts that explore how costs burden patients throughout the care trajectory and emphasized that addressing these barriers is not a one-person job.

Thank you to all the MDs who participated in the Quality Care & Health Services sessions👏⚕️🦺.

- @CharlesJiangMD discussed 3 abstracts that explore how costs burden patients throughout the care trajectory and emphasized that addressing these barriers is not a one-person job. Thank you to all the MDs who participated in the Quality Care & Health Services sessions👏⚕️🦺.
account_circle
Changchuan(Charles) Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profile Photo

We are going to see some new tricks other than forcing my patients to accept their overpaid insurance price of cancer drugs through their specialty pharmacy(when cash price is actually lower)...

account_circle
Changchuan(Charles) Jiang MD, MPH(@CharlesJiangMD) 's Twitter Profile Photo

Facing rising Neulasta costs, we've had to phase it out, even with 340B discounts. Safety net hospitals can't sustain it. We're spending much more time finding the right G-CSF biosimilars for our patients. Is this just us? Qasim Hussaini, MD

account_circle